CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 82.67% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money

Trade Regeneron Pharmaceuticals, Inc. (Extended hours) - REGN CFD

731.54
1.13%
Market Trading Hours* (UTC) Open now
Closes on Friday at 22:00

Mon: 09:00 - 00:00

Tue - Thu: 00:00 - 01:00 09:00 - 00:00

Fri: 00:00 - 01:00 09:00 - 22:00

  • Summary
  • Historical Data
Trading сonditions
Spread 0.96
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.024262 %
Charges from full value of position ($-4.61)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.024262%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.00204 %
Charges from full value of position ($0.39)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.00204%
Overnight fee time 22:00 (UTC)
Min traded quantity 0.01
Currency USD
Margin 5.00%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 739.93
Open 740.46
1-Year Change -14.18%
Day's Range 727.02 - 740.46
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Dec 13, 2024 739.45 1.50 0.20% 737.95 739.95 737.95
Dec 12, 2024 737.95 -32.02 -4.16% 769.97 776.95 737.95
Dec 11, 2024 760.95 -12.00 -1.55% 772.95 780.93 760.95
Dec 10, 2024 773.83 -7.85 -1.00% 781.68 789.60 760.89
Dec 9, 2024 780.16 4.21 0.54% 775.95 799.90 769.35
Dec 6, 2024 773.56 6.51 0.85% 767.05 777.34 762.90
Dec 5, 2024 764.36 18.25 2.45% 746.11 767.63 745.10
Dec 4, 2024 751.67 8.19 1.10% 743.48 755.99 742.26
Dec 3, 2024 748.02 -11.00 -1.45% 759.02 764.35 746.34
Dec 2, 2024 762.43 15.48 2.07% 746.95 763.61 746.95
Nov 29, 2024 744.95 -3.42 -0.46% 748.37 753.85 738.00
Nov 27, 2024 752.74 2.78 0.37% 749.96 761.95 745.63
Nov 26, 2024 750.07 7.48 1.01% 742.59 753.74 733.11
Nov 25, 2024 746.39 1.44 0.19% 744.95 757.29 741.25
Nov 22, 2024 735.86 -6.19 -0.83% 742.05 751.02 735.86
Nov 21, 2024 742.10 -0.85 -0.11% 742.95 756.64 734.06
Nov 20, 2024 740.28 -0.34 -0.05% 740.62 749.79 732.01
Nov 19, 2024 744.37 -11.58 -1.53% 755.95 757.45 734.31
Nov 18, 2024 758.64 10.31 1.38% 748.33 762.09 748.33
Nov 15, 2024 753.95 -24.00 -3.09% 777.95 779.30 752.35

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 3:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Regeneron Company profile

Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema (DME); myopic choroidal neovascularization; and diabetic retinopathy in patients with DME, as well as macular edema following retinal vein occlusion, including macular edema following central retinal vein occlusion and macular edema following branch retinal vein occlusion. It also provides Dupixent injection to treat adult patients with moderate-to-severe atopic dermatitis; Praluent injection, an adjunct to diet and maximally tolerated statin therapy for the treatment of adults with heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease; and Kevzara solution for subcutaneous injection to treat rheumatoid arthritis in adults. In addition, the company offers ARCALYST injection for cryopyrin-associated periodic syndromes; and ZALTRAP, an injection for intravenous infusion, which is used in combination with 5-fluorouracil, leucovorin, and irinotecan for the treatment of metastatic colorectal cancer. Further, it develops EYLEA, a trap-based clinical product that is in Phase III study for the treatment of neovascular glaucoma; and Dupixent, Praluent, Kevzara, Suptavumab, Cemiplimab, Fasinumab, Evinacumab, Nesvacumab/aflibercept, Trevogrumab, REGN1908-1909, REGN1979, REGN3470-3471-3479, REGN2477, REGN3500, REGN3767, and REGN3918, which are antibody-based clinical programs under various stages of development. The company has collaboration and license agreements with Sanofi, Bayer, Mitsubishi Tanabe Pharma, Teva, Intellia Therapeutics, Adicet Bio, Decibel Therapeutics, Astellas, Alnylam Pharmaceuticals, Inc., and others. Regeneron Pharmaceuticals, Inc. was founded in 1988 and is headquartered in Tarrytown, New York.
Industry: Bio Therapeutic Drugs

777 Old Saw Mill River Road
TARRYTOWN
NEW YORK 10591
US

People also watch

BTC/USD

101,388.80 Price
+1.560% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 50.00

Gold

2,649.29 Price
-1.170% 1D Chg, %
Long position overnight fee -0.0125%
Short position overnight fee 0.0043%
Overnight fee time 22:00 (UTC)
Spread 0.30

ETH/USD

3,899.42 Price
+0.770% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 1.75

XRP/USD

2.44 Price
+3.010% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 0.01217

Still looking for a broker you can trust?

Join the 660,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading